A Combined Systemic Strategy for Overcoming Cisplatin Resistance in Head and Neck Cancer: From Target Identification to Drug Discovery

SIMPLE SUMMARY: The efficiency of cisplatin is limited by drug resistance in head–neck cancer (HNC) patients. In this study, we established a cisplatin resistance (CR) cell model, generated CR related transcriptome profiling, and combined application of bioinformatics methodology to discover a possi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yin-Ju, You, Guo-Rung, Lai, Meng-Yu, Lu, Long-Sheng, Chen, Chang-Yu, Ting, Lai-Lei, Lee, Hsin-Lun, Kanno, Yuzuka, Chiou, Jeng-Fong, Cheng, Ann-Joy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700594/
https://www.ncbi.nlm.nih.gov/pubmed/33238517
http://dx.doi.org/10.3390/cancers12113482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700594/
https://www.ncbi.nlm.nih.gov/pubmed/33238517
http://dx.doi.org/10.3390/cancers12113482

Ejemplares similares